These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 25857658

  • 1. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases.
    Garg N, Reddel SW, Miller DH, Chataway J, Riminton DS, Barnett Y, Masters L, Barnett MH, Hardy TA.
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1374-82. PubMed ID: 25857658
    [Abstract] [Full Text] [Related]

  • 2. Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosum.
    Straus Farber R, Devilliers L, Miller A, Lublin F, Law M, Fatterpekar G, Delman B, Naidich T.
    J Magn Reson Imaging; 2009 Oct; 30(4):732-6. PubMed ID: 19787715
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
    Wu QZ, Yang Q, Cate HS, Kemper D, Binder M, Wang HX, Fang K, Quick MJ, Marriott M, Kilpatrick TJ, Egan GF.
    J Magn Reson Imaging; 2008 Mar; 27(3):446-53. PubMed ID: 17968901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumefactive demyelinating lesions: A literature review of recent findings.
    Al Malik YM.
    Neurosciences (Riyadh); 2024 Jul; 29(3):153-160. PubMed ID: 38981633
    [Abstract] [Full Text] [Related]

  • 12. Corpus callosum demyelination associated with acquired stuttering.
    Decker BM, Guitar B, Solomon A.
    BMJ Case Rep; 2018 Apr 21; 2018():. PubMed ID: 29680798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
    Guglielmetti C, Praet J, Rangarajan JR, Vreys R, De Vocht N, Maes F, Verhoye M, Ponsaerts P, Van der Linden A.
    Neuroimage; 2014 Feb 01; 86():99-110. PubMed ID: 23933305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis.
    Pozzilli C, Fieschi C, Perani D, Paulesu E, Comi G, Bastianello S, Bernardi S, Bettinardi V, Bozzao L, Canal N.
    J Neurol Sci; 1992 Oct 01; 112(1-2):51-7. PubMed ID: 1469440
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.
    Cocozza S, Olivo G, Riccio E, Russo C, Pontillo G, Ugga L, Migliaccio S, de Rosa D, Feriozzi S, Veroux M, Battaglia Y, Concolino D, Pieruzzi F, Tuttolomondo A, Caronia A, Russo CV, Lanzillo R, Brescia Morra V, Imbriaco M, Brunetti A, Tedeschi E, Pisani A.
    Neuroradiology; 2017 Jun 01; 59(6):563-570. PubMed ID: 28386689
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.